This insightful interview explores the disparities in neurological care and the innovative strategies aimed at transforming research and treatment for better, inclusive health outcomes.
Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal